Table 3.
Characteristics of patients with improvement, no change, or deterioration in endpoint HbA1c
| Variables | Improvement | No change | Deterioration | P |
|---|---|---|---|---|
| No. of patients (%) | 1168 (63.2) | 412 (22.3) | 267 (14.5) | |
| Baseline HbA1c (%) | ||||
| Mean (SD) | 8.25 (1.04) | 6.90 (0.91) | 6.98 (1.15) | <0.001 |
| Age (years) | ||||
| Mean (SD) | 55.50 (11.14) | 57.60 (10.69) | 58.10 (10.53) | 0.077 |
| BMI (kg/m2) | ||||
| Mean (SD) | 25.26 (3.24) | 24.88 (3.25) | 24.85 (3.26) | 0.054 |
| Duration of diabetes (years) | ||||
| Mean (SD) | 7.24 (6.15) | 7.00 (6.08) | 8.98 (6.45) | <0.001 |
| No. of patients with ≤5 years of diabetes | 507 | 192 | 81 | <0.001 |
| No. of patients with 5–10 years of diabetes | 312 | 98 | 75 | |
| No. of patients with >10 years of diabetes | 349 | 122 | 111 | |
The Cochran–Mantel–Haenszel test was used
BMI body mass index, HbA 1c glycated hemoglobin, SD standard deviation